| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aberrant T-cell antigen expression in a plasma cell neoplasm
|
Patel, Smita
|
|
|
132 |
3 |
p. 341
|
artikel
|
| 2 |
Allogeneic hematopoietic stem cell transplantation for T-cell lymphomas
|
Schmitz, Norbert
|
|
|
132 |
3 |
p. 245-253
|
artikel
|
| 3 |
Ambiguous lineage leukemia treatment
|
|
|
|
132 |
3 |
p. 343
|
artikel
|
| 4 |
Benefit of brentuximab over bleomycin in first-line treatment of advanced-stage Hodgkin lymphoma has not been proven
|
Adams, Hugo J.A.
|
|
|
132 |
3 |
p. 339-340
|
artikel
|
| 5 |
Disruption of a GATA1-binding motif upstream of XG/PBDX abolishes Xga expression and resolves the Xg blood group system
|
Möller, Mattias
|
|
|
132 |
3 |
p. 334-338
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
132 |
3 |
p. i
|
artikel
|
| 7 |
How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa
|
Gopal, Satish
|
|
|
132 |
3 |
p. 254-263
|
artikel
|
| 8 |
HSP90 inhibition without heat shock response
|
Byrd, John C.
|
|
|
132 |
3 |
p. 241-242
|
artikel
|
| 9 |
Hypomorphic Rag1 mutations alter the preimmune repertoire at early stages of lymphoid development
|
Ott de Bruin, L.M.
|
|
|
132 |
3 |
p. 281-292
|
artikel
|
| 10 |
International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia
|
Hrusak, Ondrej
|
|
|
132 |
3 |
p. 264-276
|
artikel
|
| 11 |
Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A
|
Buscarlet, Manuel
|
|
|
132 |
3 |
p. 277-280
|
artikel
|
| 12 |
Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells
|
Zhang, Yankai
|
|
|
132 |
3 |
p. 321-333
|
artikel
|
| 13 |
Phase 1 study of the PI3Kδ inhibitor INCB040093 ± JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma
|
Phillips, Tycel J.
|
|
|
132 |
3 |
p. 293-306
|
artikel
|
| 14 |
PI3K inhibitors and the search for the Holy Grail
|
Flinn, Ian W.
|
|
|
132 |
3 |
p. 240-241
|
artikel
|
| 15 |
Table of contents. Blood. 2018;131(18):ix-x.
|
|
|
|
132 |
3 |
p. 342
|
artikel
|
| 16 |
Targeting HSP90 dimerization via the C terminus is effective in imatinib-resistant CML and lacks the heat shock response
|
Bhatia, Sanil
|
|
|
132 |
3 |
p. 307-320
|
artikel
|
| 17 |
The cells are ambiguous, not the message
|
Rohrlich, Pierre S.
|
|
|
132 |
3 |
p. 239-240
|
artikel
|
| 18 |
XG blood group puzzle solved: what's next?
|
Zimmerman, Peter A.
|
|
|
132 |
3 |
p. 243
|
artikel
|
Tijdschrift beschrijving